Icatibant

Product manufactured by Cipla Usa Inc.

Application Nr Approved Date Route Status External Links
ANDA212446 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Icatibant Injection Is Indicated For The Treatment Of Acute Attacks Of Hereditary Angioedema (hae) In Adults 18 Years Of Age And Older. Icatibant Injection Is A Bradykinin B2 Receptor Antagonist Indicated For Treatment Of Acute Attacks Of Hereditary Angioedema (hae) In Adults 18 Years Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Icatibant Acetate

Comments